NYC Startup Syntimmune Names Former Biogen Exec as New CEO Post author:Sam Post published:January 2, 2018 Post category:BioPharma Syntimmune has appointed Jean-Paul Kress as president and CEO. Source: BioSpace You Might Also Like Unilife Slashes Workforce and May Not Have Enough Cash to Survive Beyond This Week April 4, 2017 PharmaCyte Presents Options for Phase II Pancreatic Cancer Trial February 27, 2018 Kedrion And Kamada Receive FDA Approval Of KEDRAB For Post-Exposure Prophylaxis Against Rabies Infection August 24, 2017
Kedrion And Kamada Receive FDA Approval Of KEDRAB For Post-Exposure Prophylaxis Against Rabies Infection August 24, 2017
